Herpesvirus infections of the nervous system

Nature Clinical Practice Neurology

Volumn 3, Issue 2, 2007, Pages 82-94

  Gilden, Donald H ^a   Mahalingam, Ravi ^a   Cohrs, Randall J ^a   Tyler, Kenneth L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; FAMCICLOVIR; FOSCARNET; GABAPENTIN; GANCICLOVIR; LIDOCAINE; NORTRIPTYLINE; PREGABALIN; STEROID; VALACICLOVIR; VALGANCICLOVIR; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BELL PALSY; BURKITT LYMPHOMA; CELL TRANSPLANTATION; CHICKENPOX; COGNITIVE DEFECT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DERMATITIS HERPETIFORMIS; DRUG DOSE ESCALATION; EPSTEIN BARR VIRUS; EXANTHEMA SUBITUM; GENITAL HERPES; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HERPES ZOSTER; HERPES ZOSTER OTICUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOPROLIFERATIVE DISEASE; MONOTHERAPY; MYELITIS; NASOPHARYNX CARCINOMA; NEURITIS; NEUROLOGIC DISEASE; NONHUMAN; OPTIC NEURITIS; POSTHERPETIC NEURALGIA; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; RADICULOPATHY; REINFECTION; REVIEW; SEIZURE; VARICELLA ZOSTER VIRUS; VASCULAR DISEASE; VIRUS ACTIVATION; VIRUS DETECTION; VIRUS ENCEPHALITIS; VIRUS ISOLATION; VIRUS LATENCY; VIRUS MENINGITIS; VIRUS PATHOGENESIS;

HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; VIRUS LATENCY;

EID: 33846918372     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0401     Document Type: Review

References (88)

1. Lakeman FD and Whitley RJ (1995) Diagnosis of herpes simplex encephalitis: Application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 171: 857-863
2. Weil AA et al. (2002) Patients with suspected herpes simplex encephalitis: Rethinking an initial negative polymerase chain reaction result. Clin Infect Dis 34: 1154-1157
3. Westmoreland BF (1987) The EEG in cerebral inflammatory processes. In Electroencephalography: Basic Principles, Clinical Applications, and Related Fields, edn 2, 259-273 (Eds Niedermeyer E and Lopes da Silva FH) Baltimore-Munich: Urban and Schwarzenberg
4. Smith JB et al. (1975) A distinctive clinical EEG profile in herpes simplex encephalitis. Mayo Clin Proc 50: 469-474
5. Zimmerman RD et al. (1980) CT in the early diagnosis of herpes simplex encephalitis. Am J Radiol 134:61-66
6. Schroth G et al. (1987) Early diagnosis of herpes simplex encephalitis by MRI. Neurology 37:179-183
7. Bastian FO et al. (1972) Herpesvirus hominis:iSolation from human trigeminal ganglion. Science 178:306-307
8. Baringer JR and Swoveland P (1973) Recovery of herpes simplex virus from human trigeminal ganglions. N Engl J Med 288:648-650
9. Warren KG et al. (1978) Herpes simplex virus latency in patients with multiple sclerosis, lymphoma and normal humans. IARC Sci Publ 765-768
10. Bustos DE and Atherton SS (2002) Detection of herpes simplex virus type 1 in human ciliary ganglia. Invest Ophthalmol Vis Sci 43: 2244-2249
11. Mahalingam R et al. (1992) Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann Neurol 31: 444-448
12. Fraser NW et al. (1981) Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci USA 78: 6461-6465
13. Sawtell NM (1997) Comprehensive quantification of herpes simplex virus latency at the single-cell level. J Virol 71: 5423-5431
14. Cohrs RJ et al. (2000) Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol 74: 1164-11471
15. Vrabec JT and Alford RL (2004) Quantitative analysis of herpes simplex virus in cranial nerve ganglia. J Neurovirol 10: 216-222
16. Rock DL and Fraser NW (1985) Latent herpes simplex virus type 1 DNA contains two copies of the virion DNA joint region. J Virol 55: 849-852
17. Stevens JG et al. (1987) RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235: 1056-1059
18. Kang W et al. (2003) Establishment and maintenance of HSV latent infection is mediated through correct splicing of the LAT primary transcript. Virology 312: 233-244
19. Izumi KM et al. (1989) Molecular and biological characterization of a type 1 herpes simplex virus (HSV-1) specifically deleted for expression of the latency-asssociated transcript (LAT). Microb Pathog 7: 121-134
20. Perng GC et al. (2000) Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287: 1500-1503
21. Gupta A et al. (2006) Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442:82-85
22. Bourne N et al. (2003) Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs. J Infect Dis 197: 542-549
23. Murakami S et al. (1996) Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 124:27-30
24. Furuta Y et al. (1992) Latent herpes simplex virus type 1 in human geniculate ganglia. Acta Neuropathol (Berl) 84:39-44
25. Gonzales N et al. (2003) Recurrent dermatomal vesicular skin lesions: A clue to diagnosis of herpes simplex virus 2 meningitis. Arch Neurol 60:868-869
26. Tedder DG et al. (1994) Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med 121:334-338
27. Yamamoto LJ et al. (1991) Herpes simplex virus type 1 DNA in cerebrospinal fluid of a patient with Mollaret's meningitis. N Engl J Med 325: 1082-1085
28. Baringer JR (1974) Recovery of herpes simplex virus from human sacral ganglions. New Engl J Med 291: 828-830
29. Krohel GB et al. (1976) Herpes simplex neuropathy. Neurology 26:596-597
30. Morris HH and Peters BH (1974) Recurrent sciatica associated with herpes simplex: Case report. J Neurosurg 41:97-99
31. Miller AE (1980) Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 30:582-587
32. Oxman MN et al. (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271-2284
33. Gilden DH et al. (2005) VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy. Neurology 65:21-25
34. Gilden DH et al. (1996) Varicella zoster virus, a cause of waxing and waning vasculitis: The New England Journal of Medicine case 5-1995 revisited. Neurology 47: 1441-1446
35. Gilden DH et al. (2002) Two patients with unusual forms of varicella-zoster virus vasculopathy. N Eng J Med 347: 1500-1503
36. Gilden DH et al. (1998) The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virus. J Neurol Sci 159: 140-144
37. Sato M et al. (1979) Herpes zoster of the maxillary branch of the trigeminus nerve: Virological and serological studies. Int J Oral Surg 8:149-154
38. Vonsover A et al. (1987) Detection of varicella-zoster virus in lymphocytes of DNA hybridization. J Med Virol 21:57-66
39. Gilden DH et al. (1988) Persistence of varicella-zoster virus DNA in blood mononuclear cells of patients with varicella or zoster. Vnis Genes 2:299-305
40. Mahalingam R et al. (1995) Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol 1: 130-133
41. Schott GC (1998) Triggering of delayed-onset postherpetic neuralgia. Lancet 351: 419-420
42. Vafai A et al. (1988) Expression of varicella-zoster virus blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci 85: 2767-2770
43. Gilden DH et al. (1994) Zoster sine herpete, a clinical variant. Ann Neurol 34:530-533
44. Terada K et al. (1998) Detection of varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsay Hunt syndrome or zoster sine herpete. J Med Virol 56: 359-363
45. Yamada S et al. (2003) Ipsilateral truncal sensory deficit in a patient with ophthalmic zoster sine herpete. Neurology 60: 1049-1050
46. Hevner RF et al. (2003) An unusual cause of trigeminal distribution pain and tumour. Lancet Neurol 2: 567-571
47. Gilden DH et al. (2003) Chronic varicella zoster virus ganglionitis - a possible cause of postherpetic neuralgia. J Neurovirol 9: 404-407
48. Quan D et al. (2006) Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. Arch Neurol 63: 940-952
49. Devlin ME et al. (1992) Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J Infect Dis 165:619-622
50. Gilden DH et al. (1983) Varicella-zoster virus DNA in human sensory ganglia. Nature 306: 478-480
51. Hyman RW et al. (1983) Varicella-zoster virus RNA in human trigeminal ganglia. Lancet 322: 814-816
52. Gilden DH et al. (1987) Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia. Ann Neurol 22: 377-380
53. Clarke P et al. (1995) Configuration of latent varicella-zoster virus DNA. J Virol 69: 8151-8154
54. Wood MJ et al. (1994) A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 330: 896-900
55. Whitley RJ et al. (1996) Acyclovir with and without prednisone for the treatment of herpes zoster: A randomized, placebo-controlled trial. Ann Intern Med 125: 376-383
56. Bennett JL et al. (1996) Epstein-Barr virus-associated acute autonomic neuropathy. Ann Neurol 40: 453-455
57. Majid A et al. (2002) Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain 125: 159-165
58. Imai S et al. (1993) Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections. J Med Virol 40: 278-284
59. Lehmbecher T et al. (1996) Activated T lymphocytes in the cerebrospinal fluid of a patient with Epstein-Barr virus-associated meningoencephalitis. Pediatr Infect Dis J 15: 631-633
60. Baumgarten E et al. (1994) Life-threatening infectious mononucleosis: Is it correlated with virus-induced T cell proliferation? Clin Infect Dis 19: 152-156
61. MacMahon EM et al. (1991) Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338: 969-973
62. Comoli P et al. (2005) Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-specific T cells. Am J Transplant 5: 1415-1422
63. Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343: 481-492
64. Rickinson A and Kieff E (2001) Epstein-Barr virus. In Virology, edn 4, 2573-2627 (Eds Knipe D et al.) Philadelphia: Lippincott Williams and Wilkins
65. Duchowny M et al. (1979) Cytomegalovirus infection of the adult nervous system. Ann Neurol 5: 458-461
66. Schneck SA (1965) Neuropathological features of human organ transplantation. I: Probable cytomegalovirus infection. J Neuropathol Exp Neurol 24: 415-429
67. Eidelberg D et al. (1986) Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 36: 912-916
68. Mocarski ES Jr and Courcelle CT (2001) Cytomegaloviruses and their replication. In Virology, edn 4, 2629-2673 (Eds Knipe D et al.) Philadelphia: Lippincott Williams and Wilkins
69. Rasmussen L et al. (2003) Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus. J Infect Dis 187: 809-819
70. Stinski MF et al. (1979) DNA of human cytomegalovirus: Size heterogeneity and defectiveness resulting from serial undiluted passage. J Virol 31: 231-239
71. Hummel M and Abecassis MM (2002) A model for reactivation of CMV from latency. J Clin Virol 25 (Suppl 2): S123-S136
72. Froberg MK (2004) CMV escapes! Ann Clin Lab Sci 34: 123-130
73. Whitley RJ et al. (1998) Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy. Arch Intern Med 158: 957-969
74. Dewhurst S (2004) Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 11 (Suppl 2): S105A-S111A
75. Asano Y et al. (1990) Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet 335: 862-863
76. Portolani M et al. (2005) Post-mortem diagnosis of encephalitis in a 75-year-old man associated with human herpesvirus-6 variant A. J Med Virol 77:244-248
77. Zerr DM et al. (2001) Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 33: 763-771
78. Wainwright MS et al. (2001) Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 50: 612-619
79. Kondo K et al. (1991) Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 72: 1401-1408
80. Kong H et al. (2003) Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death. J Neurovirol 9: 539-550
81. Dietrich J et al. (2004) Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties. J Neurosci 24: 4875-4883
82. Zerr DM et al. (2002) Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 34: 309-317
83. + T cells. Proc Natl Acad Sci USA 87: 748-752
84. Ward KN et al. (2002) Neuroinvasion during delayed primary HHV-7 infection in an immunocompetent adult with encephalitis and flaccid paralysis. J Med Virol 67: 538-541
85. Yoshikawa T et al. (2003) Human herpesvirus 7-associated meningitis and optic neuritis in a patient after allogeneic stem cell transplantation. J Med Virol 70: 440-443
86. Yoshikawa T et al. (2000) Invasion by human herpesvirus 6 and human herpesvirus 7 of the central nervous system in patients with neurological signs and symptoms. Arch Dis Child 83: 170-171
87. Chang Y et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869
88. Montaner S et al. (2006) The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res 66: 168-174